ReviewActa pharmacologica Sinica2018

GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Meng-Yi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.